,drug_name,section_name,gpt_output
0,XEOMIN,adverse reactions,"Adverse reactions: peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, blepharospasm, eye disorder, sensation of pressure, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, hypersensitivity."
1,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties"
2,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, neuromuscular disorders, clinical effects of treatment, corneal exposure, corneal ulceration, ulceration, perforation, diplopia, ptosis, asthenia, generalized muscle weakness, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, respiratory failure, aspiration, respiratory compromise, persistent epithelial defect, ectropion, narrow angle glaucoma, ecchymosis"
3,QUTENZA,adverse reactions,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
4,QUTENZA,warnings and precautions,"Eye and mucous membrane exposure, coughing, sneezing, irritation of eyes, irritation of airways, transient increases in blood pressure, procedural pain, increases in blood pressure"
5,ZYTIGA,adverse reactions,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, cardiac failure, constipation, groin pain, pyrexia, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis"
6,ZYTIGA,warnings and precautions,"mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III or IV heart failure, hypertension, hypokalemia, fluid retention, edema, myocardial infarction, ventricular arrhythmia, adrenocortical insufficiency, hepatotoxicity, ALT increases, AST increases, liver enzyme increases, liver function test abnormalities, bilirubin levels increase"
7,TOVIAZ,adverse reactions,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, angina, chest pain, gastroenteritis, QT prolongation on ECG, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, urinary retention (serious adverse event), diverticulitis (serious adverse event), irritable bowel syndrome (serious adverse event), electrocardiogram QT corrected interval prolongation (serious adverse event)"
8,TOVIAZ,warnings and precautions,"Angioedema, urinary retention, severe constipation, narrow-angle glaucoma, somnolence, headache, dizziness, anticholinergic CNS effects"
9,STRIBILD,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, lactic acidosis, severe hepatomegaly with steatosis, severe acute exacerbations of hepatitis B, new onset or worsening renal impairment, bone effects, immune reconstitution syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, AST elevation, ALT elevation, amylase elevation, creatine kinase elevation, urine RBC, bone mineral density decrease, bone fractures, proteinuria, serum creatinine increase, estimated creatinine clearance decrease, laboratory abnormalities, ALT abnormalities, alkaline phosphatase abnormalities, bilirubin abnormalities, serum glucose abnormalities, glycosuria, neutrophils abnormalities, fasting cholesterol abnormalities, fasting triglycerides abnormalities, total cholesterol increase, HDL-cholesterol increase, LDL-cholesterol increase, triglycerides increase, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, hepatic steatosis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia."
10,STRIBILD,boxed warnings,"lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B"
11,STRIBILD,warnings and precautions,"'new onset or worsening renal impairment, acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, renal impairment, acute renal failure, Fanconi syndrome, proximal renal tubular dysfunction, renal replacement therapy, acute renal failure, nephrotoxic drugs, bone pain, pain in extremities, fractures, muscular pain, weakness, proximal renal tubulopathy, renal function, decreases in bone mineral density, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome'"
12,FARXIGA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in LDL-C, bladder cancer, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, serious anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, hyperphosphatemia, increase in LDL cholesterol"
13,FARXIGA,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
14,VICTRELIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, serious infections, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
15,VICTRELIS,warnings and precautions,"Embryofetal toxicity, anemia, neutropenia, hypersensitivity reactions, pancytopenia, thromboembolic events"
16,VIMIZIM,adverse reactions,"Adverse reactions: anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue"
17,VIMIZIM,boxed warnings,"cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms (nausea, abdominal pain, retching, vomiting)"
18,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, acute respiratory complications, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute febrile, respiratory illness, sleep apnea, spinal or cervical cord compression, back pain, paralysis, urinary incontinence, fecal incontinence"
19,BEPREVE,adverse reactions,"Adverse reactions: 'mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue, throat'"
20,BEPREVE,warnings and precautions,"Answer: 'contamination, contact lens-related irritation'"
21,PRISTIQ,adverse reactions,"'hypersensitivity, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, nervousness, abnormal dreams, urinary hesitation, yawning, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion, total cholesterol increase, LDL cholesterol increase, triglycerides increase, proteinuria, supine systolic blood pressure increase, supine diastolic blood pressure increase, pulse rate increase, weight decrease, sustained hypertension, orthostatic hypotension, Stevens-Johnson syndrome'"
22,PRISTIQ,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, suicidal thoughts and behaviors"
23,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia"
24,TAFINLAR,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, new primary malignancies, tumor promotion, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, pancreatitis, hypersensitivity, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT prolongation, renal failure, dry skin, dermatitis acneiform, actinic keratosis, erythema, pruritus, dry mouth, dizziness, oropharyngeal pain, muscle spasms, pain in extremity, dehydration, insomnia, hemorrhage, urinary tract infection, back pain, cuSCC, cough, constipation, nasopharyngitis."
25,TAFINLAR,warnings and precautions,"'retinal vein occlusion, interstitial lung disease, new primary malignancies, cutaneous, non-cutaneous, tumor promotion, hemorrhage, venous thromboembolism, deep vein thrombosis, pulmonary embolism, cardiomyopathy, ocular toxicities, serious febrile reactions, pyrexia, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, embryofetal toxicity, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, non-cutaneous malignancies, pancreatic adenocarcinoma, colorectal carcinoma, head and neck carcinoma, glioblastoma, major hemorrhages, intracranial hemorrhage, gastric hemorrhage, deep venous thrombosis, retinal pigment epithelial detachment, uveitis, iritis, fever, hypotension, rigors, chills, dehydration, renal failure, skin toxicity, secondary infections, hemolytic anemia'"
26,MULTAQ,adverse reactions,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes (generalized, macular, maculo-papular, erythematous), pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine >=10%, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis"
27,MULTAQ,boxed warnings,"Answer: 'increased risk of death, stroke, heart failure'"
28,MULTAQ,warnings and precautions,"Adverse drug reactions: 'cardiac rhythm disturbances, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, teratogenic effects, cardiovascular death, heart failure, stroke, hepatocellular liver injury, acute liver failure, interstitial lung disease, pneumonitis, pulmonary fibrosis, QT interval prolongation, pre-renal azotemia, acute renal failure'"
29,TANZEUM,adverse reactions,"thyroid C-cell tumors, acute pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, increased gamma glutamyltransferase (GGT), heart rate increase"
30,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma"
31,TANZEUM,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, acute renal failure, worsening of chronic renal failure"
32,BELEODAQ,adverse reactions,"'hematologic toxicity, infection, hepatotoxicity, tumor lysis syndrome, gastrointestinal toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation, febrile neutropenia'"
33,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, embryo-fetal toxicity, nausea, vomiting, diarrhea, teratogenicity, embryo-fetal lethality"
34,HALAVEN,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, cytopenias, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus"
35,HALAVEN,warnings and precautions,"neutropenia, peripheral neuropathy, embryo-fetal toxicity, QT prolongation, severe neutropenia, Grade 4 neutropenia, febrile neutropenia, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, neuropathy lasting more than one year, new or worsening neuropathy, embryo-fetal toxicity, teratogenicity, QT prolongation, hypokalemia, hypomagnesemia"
36,XIAFLEX,adverse reactions,"tendon ruptures, injury to the injected extremity, corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, tendon rupture, blood blister, injection site hematoma, injection site swelling, ecchymosis, corporal rupture, penile ecchymoses, penile hematoma, penile ""popping"" sounds or sensations, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, severe penile hematoma, severe injection site hematoma"
37,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, serious penile injury, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, severe penile hematoma"
38,XIAFLEX,warnings and precautions,"tendon rupture, serious injury, injected finger/hand, corporal rupture (penile fracture), serious injury to the penis, hypersensitivity reactions, anaphylaxis, abnormal coagulation, flexor tendon ruptures, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), skin laceration requiring skin graft, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, localized pruritus, IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis"
39,CIMZIA,adverse reactions,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis'"
40,CIMZIA,boxed warnings,"Answer: 'serious infections, hospitalization, death, active tuberculosis, reactivation of latent tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, tuberculosis, bacterial sepsis, lymphoma, malignancies'"
41,CIMZIA,warnings and precautions,"'serious infections, invasive fungal infections, lymphoma, other malignancies, heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, worsening congestive heart failure, new onset congestive heart failure, hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, hepatitis B virus reactivation, new onset or exacerbation of central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, optic neuritis, peripheral neuropathy, pancytopenia, aplastic anemia, leukopenia, thrombocytopenia, blood dyscrasias, infection, fever, bruising, bleeding, pallor, autoantibodies, lupus-like syndrome, immunosuppression'"
42,GRANIX,adverse reactions,"'splenic rupture, acute respiratory distress syndrome, serious allergic reactions, capillary leak syndrome, tumor growth stimulatory effects on malignant cells, bone pain, leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia'"
43,GRANIX,warnings and precautions,"Splenic rupture, Acute Respiratory Distress Syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, sickle cell crisis, Capillary Leak Syndrome (CLS), tumor growth stimulatory effects on malignant cells"
44,TUDORZA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
45,TUDORZA,warnings and precautions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, bronchospasm, anaphylaxis, urticaria, rash, itching"
46,JEVTANA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, bone marrow suppression, hypersensitivity reactions, gastrointestinal adverse reactions, renal failure, embryo-fetal toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, renal failure, ventricular fibrillation, cerebral hemorrhage, dyspnea, febrile neutropenia, arrhythmia, abdominal pain, dyspepsia, fatigue, asthenia, pyrexia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, back pain, arthralgia, muscle spasms, peripheral neuropathy, dysgeusia, dizziness, headache, hematuria, dysuria, dyspnea, cough, alopecia, hypotension, sepsis, septic shock, neutropenia, hematuria, increased AST, increased ALT, increased bilirubin, fatigue, neutropenia, asthenia, pyrexia, dizziness, urinary tract infection, dehydration, febrile neutropenia, gastritis, intestinal obstruction"
47,JEVTANA,boxed warnings,"neutropenia, neutropenic deaths, hypersensitivity, generalized rash/erythema, hypotension, bronchospasm"
48,JEVTANA,warnings and precautions,"Bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, hypersensitivity, nausea, vomiting, diarrhea, gastrointestinal hemorrhage, gastrointestinal perforation, neutropenic enterocolitis, renal failure, fetal harm"
49,ILARIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, upper respiratory tract infections, serious infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, hypersensitivity, decreased white blood cells, neutrophils, platelets, elevated transaminases, elevated bilirubin"
50,ILARIS,warnings and precautions,"'serious infections, increased risk of serious infections, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, reactivation of latent tuberculosis, opportunistic infections, immunosuppression, risk of malignancies, hypersensitivity reactions, anaphylactic reactions, immunizations, live vaccines, ineffective vaccinations, macrophage activation syndrome (MAS)'"
51,AMPYRA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, seizures, urinary tract infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
52,AMPYRA,warnings and precautions,"seizures, anaphylaxis, severe allergic reactions, respiratory compromise, urticaria, angioedema, urinary tract infections"
53,SIRTURO,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, increased mortality, QT prolongation, hepatotoxicity, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, aminotransferase elevations"
54,SIRTURO,boxed warnings,"Answer: 'increased mortality, QT prolongation, death, ventricular arrhythmia, QTcF interval >500 ms'"
55,SIRTURO,warnings and precautions,"QT prolongation, ventricular arrhythmia, QTcF interval > 500 ms, hepatotoxicity, increased mortality, death, ventricular arrhythmias, myocardial infarction, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium below normal, serum magnesium below normal, serum potassium below normal, clinically significant ventricular arrhythmia, syncope, hepatic-related adverse reactions, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation, increased risk of adverse reactions"
56,ADREVIEW,adverse reactions,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
57,ADREVIEW,warnings and precautions,"'hypersensitivity reactions, anaphylactic treatment measures, serious reactions, increased radiation exposure, decreased quality of AdreView images, iodine 123 accumulation, benzyl alcohol toxicity, hypotension, metabolic acidosis, kernicterus, increased incidence of kernicterus, deaths, increased radiation dose, decreased target to background ratios, decreased cardiac uptake, increased long term risk for thyroid neoplasia, transient episode of hypertension'"
58,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness"
59,ARCAPTA,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, asthma-related death"
60,ARCAPTA,warnings and precautions,"cardiovascular effects, fatalities, immediate hypersensitivity reactions, paradoxical bronchospasm, cardiovascular effects, ECG changes, hypokalemia, hyperglycemia"
61,INTELENCE,adverse reactions,"'severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, rhabdomyolysis, toxic epidermal necrolysis'"
62,INTELENCE,warnings and precautions,"'severe skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 and 4 rashes, discontinuation due to rash, rash during first 6 weeks of therapy, higher incidence of rash in females, severe rash, rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, life-threatening reaction, fat redistribution, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome'"
63,PICATO,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, ophthalmic adverse reaction, hypersensitivity reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
64,PICATO,warnings and precautions,"eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, local skin reactions, vesiculation/pustulation, erosion/ulceration, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling"
65,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure"
66,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, image interpretation errors, radiation risk"
67,POTIGA,adverse reactions,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
68,POTIGA,boxed warnings,"retinal abnormalities, vision loss, abnormal visual acuity, retinal pigmentary abnormalities, damage to the photoreceptors"
69,POTIGA,warnings and precautions,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, urinary retention, skin discoloration, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, vision loss, retinal abnormalities, retinal pigmentary abnormalities, hydronephrosis, renal function impairment, blue skin discoloration, grey-blue skin discoloration, brown skin discoloration, mucous membrane discoloration, scleral discoloration, conjunctiva discoloration, psychosis, withdrawal seizures'"
70,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, pneumonia, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, oropharyngeal candidiasis, candidiasis, fungal oropharyngitis, back pain, bronchitis, sinusitis, cough, arthralgia, influenza, pharyngitis, pyrexia, dysphonia, oropharyngeal pain, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, extrasystoles, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
71,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, increased risk of asthma-related hospitalization"
72,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, Candida albicans infection, pneumonia, worsening of infections, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, chickenpox, measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, anaphylaxis, angioedema, rash, urticaria, cardiovascular effects, cardiac arrhythmias, supraventricular tachycardia, extrasystoles, electrocardiographic changes, T wave flattening, QTc interval prolongation, ST segment depression, bone mineral density decrease, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth velocity reduction"
73,DOTAREM,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, nephrogenic systemic fibrosis (NSF), hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions (site inflammation, extravasation, pruritus, warmth), bradycardia, tachycardia, arrhythmia, anaphylactoid reactions (cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria), coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
74,DOTAREM,boxed warnings,"Nephrogenic systemic fibrosis (NSF), fibrosis affecting the skin, muscle and internal organs"
75,DOTAREM,warnings and precautions,"'Nephrogenic Systemic Fibrosis, anaphylactoid reactions, anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, acute kidney injury, drug-induced kidney toxicity, NSF, fibrosis affecting the skin, fibrosis affecting the muscle, fibrosis affecting internal organs, circulatory collapse, hypersensitivity reactions, acute kidney injury requiring dialysis, tissue irritation'"
76,NESINA,adverse reactions,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, hypoglycemia, severe hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis'"
77,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, hypoglycemia, arthralgia, liver enzyme elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice"
78,EYLEA,adverse reactions,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal detachment, retinal tear, endophthalmitis"
79,EYLEA,warnings and precautions,"Answer: 'endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death'"
80,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia"
81,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy (PML), lymphopenia, infections, serious infections, flushing"
82,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension, hypertensive crisis, hypersensitivity, nasopharyngitis, herpes simplex, hyperuricemia, bilirubin elevations, increased AST, increased ALT, creatinine levels changes, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, back pain, arthralgia, pain in extremity, bone pain, dizziness, dysgeusia, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, pruritus, dry skin, night sweats, hyperhidrosis, hypotension, hyperglycemia, hyponatremia, hypocalcemia, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
83,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, anaphylaxis, infusion reactions, acute renal failure, skin reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), other malignancies, extravasation injury, embryo-fetal toxicity"
84,ELIQUIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hemorrhagic stroke, intracranial bleed, gastrointestinal bleed, fatal bleeding, hypersensitivity reactions, syncope, nausea, anemia, contusion, hemorrhage, postprocedural hemorrhage, transaminases increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, traumatic hematoma, periorbital hematoma, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma"
85,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, paralysis"
86,ELIQUIS,warnings and precautions,"'fatal bleeding, bleeding, blood loss, pathological hemorrhage, epidural hematoma, spinal hematoma, paralysis, neurological impairment'"
87,BOSULIF,adverse reactions,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT increased, SGOT/AST increased, lipase increased, phosphorus low, total bilirubin increased, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, anaphylactic shock, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption"
88,BOSULIF,warnings and precautions,"Gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, embryofetal toxicity, diarrhea, nausea, vomiting, abdominal pain, thrombocytopenia, anemia, neutropenia, drug induced liver injury, ALT elevation, AST elevation, transaminase elevations, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, decline in estimated glomerular filtration rate (eGFR), kidney failure"
89,GILENYA,adverse reactions,"bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, bronchitis, herpes zoster, tinea versicolor, bradycardia, migraine, nausea, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma"
90,GILENYA,warnings and precautions,"'bradycardia, atrioventricular conduction, infections, progressive multifocal leukoencephalopathy (PML), macular edema, posterior reversible encephalopathy syndrome (PRES), decrease in pulmonary function tests (PFT), liver injury, blood pressure (BP) effects, immune system effects, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, atrioventricular blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, serious infections, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, bradyarrhythmia, atrioventricular blocks, reduction in heart rate, second period heart rate decrease, first-degree AV block, second-degree AV blocks, Mobitz Types I, 2:1 AV blocks, risk of infections, peripheral lymphocyte count reduction, serious infection, herpetic infections, disseminated herpetic infections, varicella zoster virus antibody testing, vaccination, macular edema with or without visual symptoms, blurred vision, decreased visual acuity, macular edema in patients with history of uveitis or diabetes mellitus, respiratory effects, forced expiratory volume over 1 second (FEV1), diffusion lung capacity for carbon monoxide (DLCO), dyspnea, liver transaminases elevation, serum transaminase levels, hepatic dysfunction, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, fetal risk, systolic pressure increase, diastolic pressure increase, hypertension, lymphocyte counts decrease'"
91,BENLYSTA,adverse reactions,"mortality, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, fatal anaphylaxis"
92,BENLYSTA,warnings and precautions,"'mortality, serious infections, fatal infections, progressive multifocal leukoencephalopathy (PML), hypersensitivity reactions, anaphylaxis, depression, suicidality, malignancies, non-melanoma skin cancers, infusion reactions, bradycardia, myalgia, headache, rash, urticaria, hypotension, nausea, skin reactions, psychiatric events, insomnia, anxiety, serious psychiatric events, serious depression, suicides, live vaccine risks'"
93,XALKORI,adverse reactions,"Adverse reactions: 'hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, elevated transaminases, hepatotoxicity, ILD, neutropenia, lymphopenia, ALT elevation, AST elevation, hypophosphatemia, pneumonia, respiratory distress syndrome, arrhythmia, dyspnea, pneumonitis, respiratory failure, sepsis, QTc prolongation, neutropenia, ILD, ALT and AST elevation, dyspnea, pulmonary embolism, neuropathy, rash, renal cyst, ILD, hepatic failure, hypokalemia, renal cysts, visual impairment, photopsia, blurred vision, vitreous floaters, sensory neuropathy, renal cysts, complex renal cysts, local cystic invasion, abscess formation'"
94,XALKORI,warnings and precautions,"'fatal hepatotoxicity, hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, fatal interstitial lung disease, drug-related ILD/pneumonitis, QTc prolongation, symptomatic bradycardia, severe visual loss, embryotoxicity, fetotoxicity'"
95,CLEVIPREX,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation (possible pulmonary shunting)"
96,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbation of heart failure, rebound hypertension"
97,LUMIZYME,adverse reactions,"Adverse reactions: hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, local swelling, diarrhea, pruritus, edema peripheral, rash papular, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions"
98,LUMIZYME,boxed warnings,"anaphylactic reactions, hypersensitivity reactions, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload, exacerbation of cardiac compromise, exacerbation of respiratory compromise"
99,LUMIZYME,warnings and precautions,"'anaphylaxis, hypersensitivity reactions, immune-mediated reactions, acute cardiorespiratory failure, cardiac arrhythmia, sudden cardiac death, antibody development, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, urticaria, chest discomfort/pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension/increased blood pressure, flushing/feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, necrotizing skin lesions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, cardiac hypertrophy, fluid overload, ventricular arrhythmias, bradycardia, cardiac resuscitation, defibrillation, IgG antibodies, loss of motor function, ventilator dependence, inhibitory antibody activity, IgE antibodies'"
100,CERDELGA,adverse reactions,"Adverse reactions: 'fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash'"
101,CERDELGA,warnings and precautions,"ECG changes, cardiac arrhythmias, prolongation of the PR interval, prolongation of the QTc interval, prolongation of the QRS interval"
102,NEURACEQ,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, injection site reaction, erythema, irritation, pain"
103,NEURACEQ,warnings and precautions,"'image interpretation errors, false positives, radiation exposure, cancer'"
104,PROLIA,adverse reactions,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, pancreatitis, new malignancies, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, cataracts, drug-related hypersensitivity reactions, severe symptomatic hypocalcemia, severe musculoskeletal pain, marked elevation in serum PTH."
105,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover"
106,FANAPT,adverse reactions,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation'"
107,FANAPT,boxed warnings,"increased mortality, dementia-related psychosis, cardiovascular reactions (heart failure, sudden death), infectious reactions (pneumonia)"
108,FANAPT,warnings and precautions,"'increased risk of death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, weight gain, seizures, orthostatic hypotension, dizziness, tachycardia, syncope, leukopenia, neutropenia, agranulocytosis, suicide, priapism, cognitive impairment, motor impairment, hyperprolactinemia, body temperature regulation disruption, dysphagia, aspiration pneumonia'"
109,FULYZAQ,adverse reactions,"Upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
110,FULYZAQ,warnings and precautions,worsening of infectious diarrhea
111,EOVIST,adverse reactions,"nephrogenic systemic fibrosis, hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions, dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders, fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
112,EOVIST,boxed warnings,"nephrogenic systemic fibrosis, fatal fibrosis, debilitating fibrosis"
113,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, anaphylactoid/hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, shock, acute kidney injury, NSF, fibrosis affecting the skin, muscle and internal organs, rapid decrease in kidney function, drug-induced kidney toxicity, hypersensitivity reactions, anaphylactic reactions, extravasation, injection site reactions, myocyte necrosis, inflammation, falsely high or low serum iron values, impaired EOVIST imaging performance, reduced hepatic contrast, elevated serum ferritin levels, reduced hepatic contrast with high serum bilirubin"
114,ONFI,adverse reactions,"somnolence or sedation, constipation, pyrexia, lethargy, drooling, vomiting, dysphagia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, somnolence, sedation, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial and lip edema"
115,ONFI,warnings and precautions,"'somnolence, sedation, withdrawal symptoms, serious dermatological reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, depression, mood changes, thoughts about self-harm'"
116,COMETRIQ,adverse reactions,"'perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, hair color changes, depigmentation, graying, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia'"
117,COMETRIQ,boxed warnings,"perforations, fistulas, hemorrhage, hemoptysis, gastrointestinal hemorrhage"
118,COMETRIQ,warnings and precautions,"thrombotic events, myocardial infarction, cerebral infarction, arterial thromboembolic events, wound complications, dehiscence, hypertension, hypertensive crisis, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, nephrotic syndrome, reversible posterior leukoencephalopathy syndrome, embryofetal toxicity, gastrointestinal perforations, fistulas, hemorrhage, hemoptysis, venous thromboembolism, arterial thromboembolism, wound healing complications, treatment-emergent hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, slow healing of the mouth or jaw, seizures, headache, visual disturbances, confusion, altered mental function, skeletal variations, visceral variations, malformations"
119,NULOJIX,adverse reactions,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, PTLD, CNS PTLD, malignancies, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, CNS infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion-related reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation, dyslipidemia, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation'"
120,NULOJIX,boxed warnings,"'post-transplant lymphoproliferative disorder, malignancies, serious infections, increased susceptibility to infection, graft loss, death'"
121,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), other malignancies, Progressive Multifocal Leukoencephalopathy (PML), serious infections, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy (PVAN), graft loss, death, acute rejection, Grade III rejection, increased rate of acute rejection, increased grade of acute rejection, liver allograft involvement, JC virus-associated PML, BK virus infection, kidney graft loss, deteriorating renal function, increased risk of CMV disease, neurological signs, cognitive signs, behavioral signs, increased risk of developing malignancies, skin malignancies, increased risk of bacterial infections, increased risk of viral infections, increased risk of fungal infections, increased risk of protozoal infections, increased risk of tuberculosis, cytomegalovirus (CMV), herpes infections, Pneumocystis jiroveci infections, increased risk of PTLD, increased risk of PML, increased risk of PVAN, increased risk of serious outcomes, increased risk of fatal outcomes, increased risk of graft loss, increased risk of death, increased risk of liver allograft involvement, increased risk of JC virus-associated PML, increased risk of BK virus infection, increased risk of kidney graft loss, increased risk of deteriorating renal function, increased risk of CMV disease, increased risk of neurological signs, increased risk of cognitive signs, increased risk of behavioral signs, increased risk of developing malignancies, increased risk of skin malignancies, increased risk of bacterial infections, increased risk of viral infections, increased risk of fungal infections, increased risk of protozoal infections, increased risk of tuberculosis, increased risk of cytomegalovirus (CMV) infections, increased risk of herpes infections, increased risk of Pneumocystis jiroveci infections."
122,GILOTRIF,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, diarrhea, bullous skin disorders, exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, rash, dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity, ILD-like adverse reactions, sepsis, pneumonia, dyspnea, fatigue, hypokalemia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, gastrointestinal disorders, skin and subcutaneous tissue disorders, infections and infestations, metabolism and nutrition disorders, respiratory disorders, thoracic disorders, mediastinal disorders, investigations, general disorders, administration site conditions, eye disorders, laboratory abnormalities, pancreatitis"
123,GILOTRIF,warnings and precautions,"diarrhea, dehydration, renal failure, bullous skin disorders, exfoliative skin disorders, interstitial lung disease (ILD), hepatic toxicity, keratitis, embryofetal toxicity"
124,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
125,DATSCAN,warnings and precautions,"hypersensitivity reactions, skin erythema, pruritis, anaphylactic, thyroid accumulation, thyroid neoplasia"
126,KALBITOR,adverse reactions,"Adverse Reactions: 'hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, seroconversion, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies'"
127,KALBITOR,boxed warnings,"anaphylaxis, hypersensitivity reactions"
128,KALBITOR,warnings and precautions,"hypersensitivity reactions, anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
129,APTIOM,adverse reactions,"'suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS)/multiorgan hypersensitivity, anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, drug induced liver injury, abnormal thyroid function tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, ear and labyrinth disorders, vertigo, eye disorders, diplopia, blurred vision, visual impairment, gastrointestinal disorders, nausea, vomiting, diarrhea, constipation, abdominal pain, gastritis, general disorders and administration site conditions, fatigue, asthenia, gait disturbance, peripheral edema, infections and infestations, urinary tract infections, injury, poisoning and procedural complications, fall, metabolism and nutrition disorders, hyponatremia, nervous system disorders, dizziness, somnolence, headache, ataxia, balance disorder, tremor, dysarthria, memory impairment, nystagmus, psychiatric disorders, depression, insomnia, respiratory, thoracic and mediastinal disorders, cough, skin and subcutaneous tissue disorders, rash, vascular disorders, hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase'"
130,APTIOM,warnings and precautions,"'suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), anaphylactic reactions, angioedema, hyponatremia, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, drug induced liver injury, abnormal thyroid function tests'"
131,DUAVEE,adverse reactions,"cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism"
132,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), blood clots, cancer of the uterus, cancer of the breast, liver problems, bleeding disorder, gallbladder problems, loss of vision, high blood pressure, increased fats in blood, thyroid problems, fluid retention, low calcium, swelling of mouth or tongue, worsening of asthma, diabetes, epilepsy, migraines, porphyria, lupus, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
133,DUAVEE,warnings and precautions,"'cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, thyroid function, dementia, visual abnormalities, retinal vascular thrombosis, elevated blood pressure, hypertriglyceridemia, hepatic impairment, cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, laboratory test interactions, impaired glucose tolerance'"
134,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, abdominal pain, increased hepatic enzymes, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
135,KALYDECO,warnings and precautions,"Elevated transaminases, cataracts"
136,AMYVID,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity (in the presence of severe renal impairment), increased toxicity (in the presence of moderate or severe hepatic impairment), hepatotoxicity, headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
137,AMYVID,warnings and precautions,"Answer: 'image interpretation errors, false negatives, radiation risk, increased risk of cancer, unintentional radiation exposure'"
138,TIVICAY,adverse reactions,"hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, rash, depression, abnormal dreams, dizziness, nausea, diarrhea, vertigo, elevated ALT, elevated AST, creatine kinase abnormalities, hyperglycemia, elevated lipase, neutropenia, elevated total bilirubin"
139,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, immune reconstitution syndrome, inflammatory response, opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
140,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
141,ULESFIA,warnings and precautions,"Answer: 'neonatal toxicity, gasping syndrome, eye irritation, contact dermatitis'"
142,JUBLIA,adverse reactions,"'ingrown toenails, application site dermatitis, application site vesicles, application site pain'"
143,TRULICITY,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, gastrointestinal adverse reactions, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, systemic hypersensitivity, injection-site reactions, PR interval prolongation, first degree atrioventricular block, amylase increase, lipase increase"
144,TRULICITY,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma"
145,TRULICITY,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, acute renal failure, worsening of chronic renal failure, severe gastrointestinal reactions, gastrointestinal adverse reactions"
146,TEFLARO,adverse reactions,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, direct Coombs' test seroconversion, diarrhea, nausea, rash, serious adverse reactions, treatment discontinuation, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, hypersensitivity, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
147,TEFLARO,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, skin reactions, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, Direct Coombs' test seroconversion, hemolytic anemia, drug-induced hemolytic anemia, development of drug-resistant bacteria"
148,JARDIANCE,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C, urinary tract infection, female genital mycotic infections, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst, volume depletion, increased urination, impairment in renal function, hypoglycemia, genital mycotic infections, phimosis, urinary tract infections, increase in LDL-C, increase in hematocrit"
149,JARDIANCE,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
150,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions"
151,ULORIC,warnings and precautions,"'gout flare, cardiovascular thromboembolic events, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, hepatic failure, liver injury, transaminase elevations, severe drug-induced liver injury'"
152,KYPROLIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, cardiac toxicities, acute renal failure, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, posterior reversible encephalopathy syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased lymphocytes, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, myocardial infarction, upper respiratory tract infection, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, muscle spasms, insomnia, rash, embolic and thrombotic events, venous, hypertension, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, headache, dizziness, insomnia, dyspnea, epistaxis, renal failure, hypotension, dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), posterior reversible encephalopathy syndrome (PRES)"
153,KYPROLIS,warnings and precautions,"'cardiac failure, myocardial infarction, myocardial ischemia, acute renal failure, tumor lysis syndrome, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pulmonary hypertension, dyspnea, hypertension, hypertensive crisis, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, embryo-fetal toxicity'"
154,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, gastrointestinal disorders, skin and subcutaneous tissue disorders, general disorders and administration site conditions, severe immune-mediated adverse reactions, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)"
155,YERVOY,boxed warnings,"immune-mediated adverse reactions, enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy"
156,YERVOY,warnings and precautions,"immune-mediated reactions, severe reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, severe immune-mediated enterocolitis, moderate enterocolitis, intestinal perforation, complications, severe enterocolitis, hepatotoxicity, fatal hepatic failure, moderate hepatotoxicity, immune-mediated hepatitis, immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, severe dermatitis, moderate dermatitis, immune-mediated neuropathies, fatal Guillain-Barre syndrome, severe peripheral motor neuropathy, Guillain-Barre-like syndromes, severe neuropathies, moderate neuropathy, severe to life-threatening immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, severe endocrinopathies, moderate endocrinopathy, hyperthyroidism, Cushing's syndrome, hypophysitis, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis"
157,GADAVIST,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, nephrogenic systemic fibrosis, hypersensitivity reactions, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, hypersensitivity/anaphylactoid reactions, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor"
158,GADAVIST,boxed warnings,"nephrogenic systemic fibrosis, fatal fibrosis, debilitating fibrosis"
159,GADAVIST,warnings and precautions,"nephrogenic systemic fibrosis, anaphylactic reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, acute kidney injury, chronic kidney disease, severe kidney disease, moderate kidney disease, mild kidney disease, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, surgery-related kidney injury, severe infection-related kidney injury, injury-related kidney injury, drug-induced kidney toxicity, NSF risk, repeated doses, higher than recommended doses, hemodialysis, hypersensitivity reactions, bronchial asthma, allergic disorders, trained personnel for resuscitation, delayed reactions, chronic renal impairment, dialysis, extravasation, moderate irritation, overestimation of malignant disease"
160,OTEZLA,adverse reactions,"'diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)'"
161,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, drug interactions, loss of efficacy, suicidal ideation, suicidal behavior, weight loss"
162,DYSPORT,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, cervical dystonia, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, blood glucose increase, electrocardiographic findings, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site bruising, injection site reaction, injection site swelling, injection site erythema, injection site haematoma, facial paresis, hypoesthesia, erythema, excessive granulation tissue, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, gait disturbance, hypertonia, sensation of heaviness, immunogenicity, antibodies formation, binding antibodies, neutralizing antibodies."
163,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
164,DYSPORT,warnings and precautions,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, severe dysphagia, aspiration, respiratory failure, eyelid ptosis, severe dysphagia, respiratory compromise"
165,FIRAZYR,adverse reactions,"'injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache'"
166,FIRAZYR,warnings and precautions,laryngeal attacks
167,INVOKANA,adverse reactions,"'hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C, female genital mycotic infections, urinary tract infections, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy, asthenia, pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, volume depletion-related adverse reactions, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, candidal balanitis, balanoposthitis, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in hemoglobin, decreases in bone mineral density'"
168,INVOKANA,warnings and precautions,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
169,XTANDI,adverse reactions,"seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, falls and fall-related injuries, hypertensive crisis"
170,XTANDI,warnings and precautions,'seizure'
171,AFINITOR,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, non-infectious pneumonitis, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hypercholesterolemia, hyperglycemia, increased aspartate transaminase (AST), anemia, leukopenia, thrombocytopenia, lymphopenia, increased alanine transaminase (ALT), hypertriglyceridemia, dyspnea, pneumonitis, vomiting, constipation, dry mouth, pyrexia, weight decreased, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, epistaxis, pruritus, alopecia, hot flush, hemoglobin decreased, WBC decreased, platelets decreased, glucose increased, cholesterol increased, potassium decreased, creatinine increased, abdominal pain, fever, headache, stomatitis, rash, diarrhea, fatigue, edema, abdominal pain, nausea, fever, headache, vomiting, constipation, dry mouth, fatigue/malaise, edema (general and peripheral), fever, asthenia, nasopharyngitis/rhinitis/URI, urinary tract infection, weight decreased, decreased appetite, diabetes mellitus, arthralgia, back pain, pain in extremity, muscle spasms, headache/migraine, dysgeusia, dizziness, insomnia, cough/productive cough, epistaxis, dyspnea/dyspnea exertional, pneumonitis, oropharyngeal pain, rash, nail disorders, pruritus/pruritus generalized, dry skin/xeroderma, hypertension, hemoglobin decreased, lymphocytes decreased, platelets decreased, WBC decreased, neutrophils decreased, alkaline phosphatase increased, glucose (fasting) increased, cholesterol increased, bicarbonate decreased, aspartate transaminase (AST) increased, alanine transaminase (ALT) increased, phosphate decreased, triglycerides increased, calcium decreased, potassium decreased, creatinine increased, sodium decreased, albumin decreased, bilirubin increased, potassium increased, stomatitis, infections, asthenia, fatigue, cough, diarrhea, anorexia, headache, dysgeusia, pain in extremity, abdominal pain, dyspnea, dehydration, pneumonitis, anemia, hypercholesterolemia, hypertriglyceridemia, lymphopenia, increased creatinine, hypophosphatemia, hyperglycemia, stomatitis, vomiting, diarrhea, peripheral edema, upper respiratory tract infection, arthralgia, cough, acne, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, epistaxis, decreased appetite, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, pneumonitis, angioedema, stomatitis, respiratory tract infection, pyrexia, pneumonia, gastroenteritis, aggression, agitation, rash, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy."
172,AFINITOR,warnings and precautions,"'non-infectious pneumonitis, fatal cases, infections, fatal, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, fatal outcome, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, surgical intervention, laboratory test alterations, serum creatinine elevations, urinary protein, blood glucose elevations, lipid elevations, hemoglobin decreases, neutrophils decreases, platelets decreases, vaccinations, live vaccines, embryo-fetal toxicity, fetal harm'"
173,ENTEREG,adverse reactions,dyspepsia
174,ENTEREG,boxed warnings,myocardial infarction
175,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea and vomiting, diarrhea, serious adverse reactions, dose-related serious adverse reactions"
176,COARTEM,adverse reactions,"'headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, chills, fatigue, malaise, rhinitis, Plasmodium falciparum infection, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption)'"
177,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, electrolyte balance disturbances, decreased exposure to lumefantrine, decreased efficacy, decreased concentrations of substrate, potential loss of substrate efficacy, increased concentrations of artemether and/or lumefantrine, QT prolongation potentiation, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, increased plasma concentrations of coadministered drug, increased risk of adverse effects, recrudescence, severe hepatic impairment, severe renal impairment, relapsing malaria"
178,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, ALT elevations"
179,DALVANCE,warnings and precautions,"hypersensitivity reactions, skin reactions, anaphylactic reactions, infusion reactions, ALT elevations, Clostridium difficile-associated diarrhea (CDAD), flushing of the upper body, urticaria, pruritus, rash, liver test abnormalities, increased morbidity, mortality, fluid and electrolyte management, protein supplementation, surgical evaluation, development of drug-resistant bacteria"
180,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
181,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, infections, death"
182,FERRIPROX,warnings and precautions,"agranulocytosis, neutropenia, infection, fetal harm, embryofetal death, malformations, increased ALT values, increased AST levels, decreased plasma zinc concentrations"
183,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, diarrhea, dyspepsia, nausea, upper abdominal pain, major bleeding, intracranial hemorrhage, hemorrhagic stroke, gastrointestinal bleeds, fatal bleeding, non-intracranial fatal bleed, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding in a critical area or organ, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, clinical myocardial infarction, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, angioedema, thrombocytopenia, esophageal ulcer"
184,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, paralysis"
185,PRADAXA,warnings and precautions,"serious and fatal bleeding, thrombotic events, epidural or spinal hematoma, long-term or permanent paralysis, thromboembolic events (valve thrombosis, stroke, transient ischemic attack, myocardial infarction), major bleeding (post-operative pericardial effusions requiring intervention for hemodynamic compromise)"
186,VORAXAZE,adverse reactions,"Adverse reactions: 'serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, paresthesia, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor'"
187,VORAXAZE,warnings and precautions,"Answer: 'serious allergic reactions, anaphylactic reactions'"
188,HORIZANT,adverse reactions,"'somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, confusional state, breast enlargement, gynecomastia, elevated creatine kinase'"
189,HORIZANT,warnings and precautions,"driving impairment, somnolence/sedation, dizziness, suicidal thoughts or behaviors, depression, suicidal thoughts or behavior, mood or behavior changes, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), multiorgan hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, tumors, breast cancer, brain tumors, lung cancer, adrenal tumor, non-Hodgkin's lymphoma, endometrial carcinoma in situ, prostate cancer"
190,STENDRA,adverse reactions,"'headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, color vision change, non-arteritic anterior ischemic optic neuropathy (NAION)'"
191,STENDRA,warnings and precautions,"hypotension, erection lasting greater than 4 hours, sudden loss of vision, sudden decrease or loss of hearing, symptomatic hypotension (e.g., dizziness, lightheadedness, fainting), prolonged erection, priapism, non-arteritic anterior ischemic optic neuropathy (NAION), tinnitus, dizziness, headache, orthostatic signs and symptoms (including increase in heart rate, decrease in standing blood pressure), effects on bleeding"
192,ADCETRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, toxic epidermal necrolysis"
193,ADCETRIS,boxed warnings,"progressive multifocal leukoencephalopathy (PML), JC virus infection, death"
194,ADCETRIS,warnings and precautions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, hepatotoxicity, pulmonary toxicity, serious dermatologic reactions, embryo-fetal toxicity, severe neutropenia, Grade 3 or Grade 4 thrombocytopenia, anemia, febrile neutropenia, pneumonia, bacteremia, sepsis, septic shock, progressive multifocal leukoencephalopathy, pneumonitis, interstitial lung disease, acute respiratory distress syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, fetal harm, embryo-fetal toxicities, decreased embryo viability, fetal malformations"
195,ZERBAXA,adverse reactions,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders: tachycardia, angina pectoris, gastrointestinal disorders: ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions: infusion site reactions, infections and infestations: candidiasis, oropharyngeal, fungal urinary tract infection, investigations: increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders: hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders: ischemic stroke, respiratory, thoracic and mediastinal disorders: dyspnea, skin and subcutaneous tissue disorders: urticaria, vascular disorders: venous thrombosis"
196,ZERBAXA,warnings and precautions,"decreased efficacy, serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis, development of drug-resistant bacteria"
197,ZYDELIG,adverse reactions,"Peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate or severe hepatic impairment, hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, sepsis, febrile neutropenia, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
198,ZYDELIG,boxed warnings,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation"
199,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder"
200,SIMPONI,adverse reactions,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, infusion reactions, immunogenicity, infections and infestations, vascular disorders, skin and subcutaneous disorders, general disorders and administration site conditions, blood and lymphatic disorders, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, investigations, nervous system disorders, gastrointestinal disorders, neoplasm benign and malignant, immune system disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders"
201,SIMPONI,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, hospitalization, death, tuberculosis, bacterial sepsis, invasive fungal infections, histoplasmosis, sepsis, latent tuberculosis, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, malignancy, lymphoma, other malignancies"
202,SIMPONI,warnings and precautions,"'serious infections, invasive fungal infections, hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, hypersensitivity reactions, anaphylaxis, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, worsening congestive heart failure, new onset congestive heart failure, central nervous system demyelinating disorders, multiple sclerosis, peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia'"
203,BLINCYTO,adverse reactions,"Adverse reactions: cytokine release syndrome, neurological toxicities, infections, tumor lysis syndrome, neutropenia, febrile neutropenia, effects on ability to drive and use machines, elevated liver enzymes, leukoencephalopathy, preparation and administration errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm"
204,BLINCYTO,boxed warnings,"Cytokine release syndrome, neurological toxicities"
205,BLINCYTO,warnings and precautions,"Cytokine Release Syndrome, life-threatening or fatal CRS, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation, capillary leak syndrome, hemophagocytic lymphohistiocytosis/macrophage activation syndrome, neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, serious infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, Tumor Lysis Syndrome, Neutropenia, febrile neutropenia, seizures, loss of consciousness, Elevated Liver Enzymes, transient elevations in liver enzymes, Grade 3 or greater elevations in liver enzymes, Leukoencephalopathy, Preparation and Administration Errors, underdose, overdose"
206,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, migraines, breast pain, menstrual disorders, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, acne, mood changes, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis"
207,NATAZIA,boxed warnings,serious cardiovascular events
208,NATAZIA,warnings and precautions,"thrombotic event, jaundice, uncontrolled hypertension, hypertension with vascular disease, significant change in headaches, irregular bleeding, amenorrhea, decreased contraceptive efficacy, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, thromboembolic disease, retinal vein thrombosis, breast cancer, cervical cancer, intraepithelial neoplasia, hepatocellular carcinoma, cholestasis, gallbladder disease, glucose tolerance, dyslipidemia, hypertriglyceridemia, pancreatitis, recurrent headaches, persistent headaches, severe headaches, breakthrough bleeding, spotting, intracyclic bleeding, depression, hereditary angioedema, chloasma"
209,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
210,DIFICID,warnings and precautions,"Acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash"
211,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema"
212,EDARBI,boxed warnings,"fetal toxicity, injury, death"
213,EDARBI,warnings and precautions,"fetal toxicity, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, death, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
214,IMBRUVICA,adverse reactions,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, pneumonia, abdominal pain, atrial fibrillation, skin infections, renal failure, creatinine increased, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, headache, hyperuricemia, infections, subdural hematomas, stomatitis, sinusitis, skin infection, urinary tract infection, pyrexia, peripheral edema, asthenia, chills, cough, oropharyngeal pain, dyspnea, arthralgia, muscle spasms, peripheral neuropathy, decreased appetite, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, petechiae, pruritus, arthropathy, epistaxis, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema'"
215,IMBRUVICA,warnings and precautions,"hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, infections, fever, progressive multifocal leukoencephalopathy (PML), cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, arrhythmic symptoms, palpitations, lightheadedness, dyspnea, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights"
216,DUREZOL,adverse reactions,"'elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis'"
217,DUREZOL,warnings and precautions,"IOP increase, glaucoma, damage to the optic nerve, defects in visual acuity and fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, corneal or scleral perforations, bacterial infections, secondary ocular infections, viral infections, exacerbation of viral infections, fungal infections, corneal ulceration"
218,ZYKADIA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, severe or persistent gastrointestinal toxicity, interstitial lung disease/pneumonitis, QT interval prolongation, hyperglycemia, bradycardia, pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, hemoglobin decreased, alanine transaminase (ALT) increased, aspartate transaminase (AST) increased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin (total) increased"
219,ZYKADIA,warnings and precautions,"'gastrointestinal toxicity, diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, interstitial lung disease (ILD), pneumonitis, QT interval prolongation, hyperglycemia, bradycardia, pancreatitis, embryofetal toxicity'"
220,CHOLINE,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, injection site reaction"
221,CHOLINE,warnings and precautions,"'imaging errors, allergic reactions, radiation risk, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, anaphylaxis, cancer risk'"
222,ERWINAZE,adverse reactions,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergic reactions, coagulopathy, hyperlipidemia, ketoacidosis, CNS events (including cerebral venous thrombosis), hepatobiliary disorders, immunogenicity (development of anti-drug antibodies)"
223,ERWINAZE,warnings and precautions,"hypersensitivity reactions, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
224,SAPHRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hypersensitivity reactions, oral ulcers, blisters, peeling/sloughing, inflammation, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT interval prolongation, hyperprolactinemia, seizures, cognitive impairment, motor impairment, body temperature regulation, suicide, dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, depression, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, tachycardia, heart rate increased, glossodynia, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, edema peripheral, dystonia, bradykinesia, muscle contractions involuntary, muscle twitching, musculoskeletal stiffness, protrusion tongue, resting tremor, tremor, galactorrhea, dysmenorrhea, gynecomastia, anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, choking, oropharyngeal muscular dysfunction, hypoesthesia"
225,SAPHRIS,boxed warnings,Answer: 'increased mortality in elderly patients with dementia-related psychosis'
226,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hyperglycemia, dyslipidemia, weight gain, hypersensitivity reactions, anaphylaxis, angioedema, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT prolongation, seizures, cognitive and motor impairment, suicide, dysphagia, aspiration pneumonia, increased mortality, death, cardiovascular events, heart failure, sudden death, infectious events, pneumonia, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, body temperature regulation, pyrexia, feeling hot"
227,CARBAGLU,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
228,CARBAGLU,warnings and precautions,"Hyperammonemia, brain injury, death, brain damage"
229,PROMACTA,adverse reactions,"hepatic decompensation, hepatotoxicity, thrombotic/thromboembolic complications, cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, cataract, abdominal pain, toothache, vitamin D deficiency, thrombotic microangiopathy, acute renal failure"
230,PROMACTA,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, hepatic decompensation"
231,PROMACTA,warnings and precautions,"hepatic decompensation, ascites, encephalopathy, liver enzyme elevations, indirect hyperbilirubinemia, clinical symptoms of liver injury, hepatic decompensation, thrombotic event, portal venous system events, venous events, arterial events, thromboembolism, portal vein thrombosis (PVT), abdominal pain, nausea, vomiting, diarrhea, cataracts"
232,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
233,BESIVANCE,warnings and precautions,"Answer: 'growth of resistant organisms, overgrowth of non-susceptible organisms, super-infection'"
234,INLYTA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, lipase increased, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
235,INLYTA,warnings and precautions,"'hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, thyroid hormone replacement, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, liver enzyme elevation, wound healing complications, elevation of liver enzymes, hepatic impairment, fetal harm'"
236,NORTHERA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, supine hypertension, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope"
237,NORTHERA,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, supine hypertension"
238,NORTHERA,warnings and precautions,"supine hypertension, hyperpyrexia, confusion, exacerbation of ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions"
239,ADCETRIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, toxic epidermal necrolysis, Stevens-Johnson syndrome, tumor lysis syndrome, embryo-fetal toxicity"
240,ADREVIEW,all-concat,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, benzyl alcohol toxicity, Gasping Syndrome, hypotension, metabolic acidosis, kernicterus, increased radiation exposure, thyroid neoplasia, hypertension"
241,AFINITOR,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, non-infectious pneumonitis, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, leukopenia, thrombocytopenia, lymphopenia, hypertriglyceridemia, anemia, hypophosphatemia, neutropenia, hypercholesterolemia, bicarbonate decreased, increased aspartate transaminase (AST), increased alanine transaminase (ALT), glucose increased, cholesterol increased, triglycerides increased, albumin decreased, potassium decreased, creatinine increased, hemoglobin decreased, WBC decreased, platelets decreased, lymphocytes decreased, neutrophils decreased, alkaline phosphatase increased, glucose (fasting) increased, cholesterol increased, bicarbonate decreased, aspartate transaminase (AST) increased, alanine transaminase (ALT) increased, phosphate decreased, triglycerides increased, calcium decreased, potassium decreased, creatinine increased, sodium decreased, bilirubin increased, potassium increased, abdominal pain, dry mouth, hemorrhoids, dysphagia, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, insomnia, dizziness, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, renal failure, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, elevated partial thromboplastin time, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy, non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, laboratory test alterations, vaccinations, embryo-fetal toxicity"
242,AMPYRA,all-concat,"seizures, anaphylaxis, urinary tract infections, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
244,APTIOM,all-concat,"Adverse reactions: peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), multiorgan hypersensitivity, anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, drug induced liver injury, abnormal thyroid function tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, ear and labyrinth disorders, eye disorders, gastrointestinal disorders, general disorders and administration site conditions, infections and infestations, injury, poisoning and procedural complications, metabolism and nutrition disorders, nervous system disorders, psychiatric disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, vascular disorders, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase, cognitive dysfunction, visual changes, serious dermatologic reactions including Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, laryngeal edema, gait disturbance, peripheral edema, urinary tract infections, fall, balance disorder, dysarthria, memory impairment, nystagmus, depression, insomnia, cough, rash, hypertension, decreases in serum T3 and T4."
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, hypokalemia, hyperglycemia"
246,BELEODAQ,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, febrile neutropenia, leukopenia (neutropenia and lymphopenia), sepsis, gastrointestinal toxicity (nausea, vomiting, diarrhea), embryo-fetal toxicity, teratogenicity, embryo-fetal lethality"
247,BENLYSTA,all-concat,"mortality, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, immunization, progressive multifocal leukoencephalopathy (PML), nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, fatal anaphylaxis, infections, upper respiratory tract infection, urinary tract infection, sinusitis, influenza, pneumonia, cellulitis, lupus nephritis, JC virus-associated PML, neurological deficits, cardiovascular disease, suicide, non-melanoma skin cancers, rash, fatigue, myalgia, headache, facial edema, bradycardia, urticaria, hypotension, psychiatric events, anxiety, suicidal behavior, live vaccines, intravenous cyclophosphamide"
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache, growth of resistant organisms, super-infection"
250,BLINCYTO,all-concat,"cytokine release syndrome, neurological toxicities, infections, tumor lysis syndrome, neutropenia, febrile neutropenia, effects on ability to drive and use machines, elevated liver enzymes, leukoencephalopathy, preparation and administration errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm"
251,BOSULIF,all-concat,"Adverse reactions: gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, lipase greater than 2*ULN, phosphorus low, total bilirubin greater than 3.0*ULN, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption."
252,BREO,all-concat,"Adverse reactions: asthma-related death, asthma-related hospitalization, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, pharyngitis, rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, pneumonia, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, paradoxical bronchospasm, hypokalemia, hyperglycemia"
253,CARBAGLU,all-concat,"infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, hyperammonemia, brain injury, death"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, ECG changes, cardiac arrhythmias"
255,CHOLINE,all-concat,"mild injection site reaction, imaging errors, allergic reactions, radiation risk, tissue inflammation, false positive 11 C-choline PET images, false negative results, increased risk for cancer"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, upper respiratory infections, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, active tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, opportunistic pathogens, Legionella, Listeria, lymphoma, hepatosplenic T-cell lymphoma, leukemia, worsening congestive heart failure, new onset congestive heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia, lupus-like syndrome"
257,CLEVIPREX,all-concat,"Adverse reactions: 'hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, serious adverse events, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation, negative inotropic effects, rebound hypertension'"
258,COARTEM,all-concat,"'headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, QT prolongation, hepatomegaly, splenomegaly, anemia, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, pruritus, rash, vertigo, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption)'"
259,COMETRIQ,all-concat,"'perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone, gastrointestinal perforations, fistula formation, hemoptysis, gastrointestinal hemorrhage, myocardial infarction, cerebral infarction, arterial thromboembolism, dehiscence, hypertensive crisis, nephrotic syndrome, embryofetal toxicity, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, persistent jaw pain, slow healing of the mouth or jaw, seizures, headache, visual disturbances, confusion, altered mental function, hepatotoxicity'"
260,DALVANCE,all-concat,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, anaphylactic reactions, skin reactions, ""Red-Man Syndrome"""
261,DATSCAN,all-concat,"Adverse reactions: 'hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain, skin erythema'"
262,DIFICID,all-concat,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
263,DOTAREM,all-concat,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
264,DUAVEE,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism, endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis, blood clots, cancer of the uterus, breast cancer, cancer of the ovary, dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, new breast lumps, unusual vaginal bleeding, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, upset stomach, throat pain, neck pain, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, past history of cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of other conditions, impaired glucose tolerance."
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis, glaucoma, defects in visual acuity and fields of vision, posterior subcapsular cataract, delayed healing, bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"Peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, cervical dystonia, blurred vision, diplopia, reduced visual acuity, accommodation, disturbance in attention, eyelid disorder, feeling abnormal, dysphagia, breathing difficulty, dyspnea, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, eyelid ptosis, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, depression, erythema, excessive granulation tissue, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, gait disturbance, hypertonia, sensation of heaviness."
267,EDARBI,all-concat,"diarrhea, hypotension/orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema, fetal toxicity, oliguria, progressive azotemia, acute renal failure, death"
268,ELIQUIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hemorrhagic stroke, gastrointestinal bleed, fatal bleeding, intracranial bleeding, non-intracranial bleeding, hypersensitivity reactions, syncope, nausea, anemia, contusion, hemorrhage, postprocedural hemorrhage, transaminases increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, hematemesis, melena, anal hemorrhage, wound hemorrhage, postprocedural hemorrhage, traumatic hematoma, periorbital hematoma, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma"
269,ENTEREG,all-concat,"Adverse reactions: dyspepsia, myocardial infarction, abdominal pain, nausea, vomiting, diarrhea"
270,EOVIST,all-concat,"Adverse reactions: nephrogenic systemic fibrosis (NSF), hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, acute kidney injury, myocyte necrosis and inflammation (due to intramuscular administration), false serum iron determination results, reduced hepatic contrast in severe renal or hepatic failure."
271,ERWINAZE,all-concat,"'hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperbilirubinemia, hyperlipidemia, ketoacidosis, CNS events, allergic reactions, thrombotic events, hemorrhagic events, hepatobiliary disorders, pancreatic disorders, hyperglycemia, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III'"
272,EYLEA,all-concat,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, arterial thromboembolic events"
273,FANAPT,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, increased mortality, cerebrovascular adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome (NMS), tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, seizures, leukopenia, neutropenia, agranulocytosis, hyperprolactinemia, body temperature regulation, dysphagia, suicide, priapism, cognitive and motor impairment"
274,FARXIGA,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in low-density lipoprotein cholesterol (LDL-C), bladder cancer, female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, increase in hematocrit, increase in serum inorganic phosphorus, increase in low-density lipoprotein cholesterol"
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, laryngeal attacks"
277,FULYZAQ,all-concat,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
278,GADAVIST,all-concat,"Adverse reactions: peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, nephrogenic systemic fibrosis (NSF), hypersensitivity reactions, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, acute kidney injury, extravasation, overestimation of extent of malignant disease in MRI of the breast."
279,GILENYA,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, bradycardia, migraine, nausea, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphomas, varicella zoster, herpes simplex infections, cryptococcal infections, varicella zoster virus, decrease in pulmonary function tests, fetal harm, blood pressure effects, immune system effects'"
280,GILOTRIF,all-concat,"Adverse reactions: 'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate or severe hepatic impairment, hepatotoxicity, diarrhea, bullous skin disorders, exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, hypokalemia, aspartate aminotransferase increased, pancreatitis, renal failure, bullous, blistering, exfoliating lesions, palmar-plantar erythrodysesthesia syndrome, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, liver test abnormalities, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, embryofetal toxicity, abortions'"
281,GRANIX,all-concat,"'splenic rupture, acute respiratory distress syndrome, serious allergic reactions, capillary leak syndrome, tumor growth stimulatory effects, bone pain, leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, allergic reactions, anaphylaxis, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, sickle cell crisis'"
282,HALAVEN,all-concat,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash"
283,HORIZANT,all-concat,"'somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts or behaviors, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, withdrawal seizure, pancreatic acinar cell adenoma, carcinoma, tumors'"
284,ILARIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, tonsillitis, urinary tract infection, viral infection, abdominal pain (upper), hypersensitivity, white blood cell decrease, neutrophils decrease, platelets decrease, transaminases elevation, bilirubin elevation, tuberculosis, immunosuppression, macrophage activation syndrome"
285,IMBRUVICA,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate or severe hepatic impairment, hepatotoxicity, hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, pyrexia, asthenia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, renal failure, creatinine increased, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, sinusitis, urinary tract infection, stomatitis, dyspepsia, petechiae, oropharyngeal pain, arthropathy, pruritus, gastroesophageal reflux disease, skin cancer, laceration, anxiety, insomnia, hypertension, vision blurred, contusion, embryo-fetal toxicity, anaphylactic shock, urticaria, angioedema, progressive multifocal leukoencephalopathy (PML)'"
286,INLYTA,all-concat,"Adverse reactions: diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia, hypertensive crisis, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, elevation of liver enzymes, hepatic impairment, fetal development"
287,INTELENCE,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, severe skin reactions, hypersensitivity reactions, rash, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, haemorrhagic stroke, DRESS, rhabdomyolysis, toxic epidermal necrolysis, severe hypersensitivity, liver transaminase elevations, fat redistribution, immune reconstitution syndrome, autoimmune disorders"
288,INVOKANA,all-concat,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C, peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, urinary tract infections, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy, asthenia, pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reactions, volume depletion-related adverse reactions, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in hemoglobin, decreases in bone mineral density"
289,JARDIANCE,all-concat,"'hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst, volume depletion, dehydration, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increases, eGFR decreases, phimosis, asymptomatic bacteriuria, cystitis, vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis, balanoposthitis, balanitis, scrotal abscess, penile infection, hematocrit increase'"
290,JEVTANA,all-concat,"Bone marrow suppression, hypersensitivity reactions, gastrointestinal adverse reactions, renal failure, embryo-fetal toxicity, neutropenia, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, renal failure, ventricular fibrillation, cerebral hemorrhage, dyspnea, febrile neutropenia, arrhythmia, abdominal pain, dyspepsia, fatigue, asthenia, pyrexia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, back pain, muscle spasms, dizziness, headache, dysuria, hypotension, gastritis, intestinal obstruction, neutropenic deaths, generalized rash/erythema, hypotension, bronchospasm, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, ileus, enterocolitis, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, febrile neutropenia, obstructive uropathy."
291,JUBLIA,all-concat,"Ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, seroconversion, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, rash"
293,KALYDECO,all-concat,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, abdominal pain, increased hepatic enzymes, hypoglycemia, rhinitis, aspartate aminotransferase increased, bacteria in sputum, blood glucose increased, hepatic enzyme increased, arthralgia, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, cataracts"
294,KYPROLIS,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, cardiac toxicities, acute renal failure, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased lymphocytes, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, asthenia, nasopharyngitis, bronchitis, hypocalcemia, hyperglycemia, insomnia, embolic and thrombotic events, venous, rash, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, dizziness, cardiac failure, pulmonary edema, decreased ejection fraction, restrictive cardiomyopathy, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, pulmonary arterial hypertension, hypertensive crisis, hypertensive emergency, musculoskeletal chest pain, embolic and thrombotic events, venous (including deep vein thrombosis and pulmonary embolism)'"
295,LUMIZYME,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity reactions, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, rash erythematous, rash macular, maculo-papular rash, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, chest pain/discomfort, supraventricular tachycardia, local swelling, diarrhea, pruritus, papular rash, delayed-onset reactions, hyperhidrosis, fatigue, myalgia, nausea, peripheral edema, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, flu-like illness, chills, arthralgia, pain, anaphylactic reactions, immune-mediated reactions, cardiorespiratory failure, exacerbation of cardiac or respiratory compromise, fluid overload, cardiac arrhythmia, sudden cardiac death, severe cardiac and skeletal muscle weakness, ventricular arrhythmias, bradycardia, cardiac arrest, death, cardiac resuscitation, defibrillation, antibody development, reduced clinical efficacy, loss of motor function, ventilator dependence'"
296,MULTAQ,all-concat,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, increases in creatinine, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis, increased risk of death, stroke, heart failure, increased risk of stroke, hepatocellular liver injury, acute liver failure, pre-renal azotemia, acute renal failure"
297,NATAZIA,all-concat,"Adverse reactions: 'serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, irregular uterine bleeding, headache (including migraines), breast tenderness, pain, menstrual disorders, nausea/ or vomiting, acne, mood changes, increased weight, menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding), mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying), headache (including migraines), weight increased, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms (for example, abdominal pain), vulvovaginal candidiasis, thrombotic event, arterial or venous thrombotic event (VTE), thromboembolic disease, cerebrovascular events (thrombotic and hemorrhagic strokes), myocardial infarctions, retinal vein thrombosis, carcinoma of the breasts and reproductive organs, cervical cancer, intraepithelial neoplasia, liver disease, hepatocellular carcinoma, gallbladder disease, carbohydrate and lipid metabolic effects, pancreatitis, headache, bleeding irregularities, depression, interference with laboratory tests, hereditary angioedema, chloasma'"
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
299,NEURACEQ,all-concat,"injection site reaction consisting of erythema, injection site irritation, injection site pain, image interpretation errors, radiation risk"
300,NORTHERA,all-concat,"'supine hypertension, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, falls, urinary tract infections, syncope, allergic reactions, exacerbate existing ischemic heart disease, exacerbate arrhythmias, exacerbate congestive heart failure, neuroleptic malignant syndrome, fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, exacerbate supine hypertension, cardiovascular events, allergic-type reactions, bronchial asthma'"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, anaphylaxis, drug hypersensitivity, hypotension, hypertension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, infections, infestations, upper respiratory infection, nasopharyngitis, influenza, bronchitis, hyperkalemia, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, graft dysfunction, peripheral edema, leukopenia, hematuria, proteinuria, dysuria, renal tubular necrosis, hypertension, hypotension, cough, dyspnea, blood creatinine increased, arthralgia, back pain, headache, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
302,ONFI,all-concat,"Adverse reactions: peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate or severe hepatic impairment, hepatotoxicity, somnolence, sedation, potentiation of sedation, central nervous system depressants, withdrawal symptoms, serious dermatological reactions, physical and psychological dependence, suicidal behavior and ideation, constipation, pyrexia, lethargy, drooling, vomiting, dysphagia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, ataxia, aggression, insomnia, psychomotor hyperactivity, dysarthria, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial and lip edema, Stevens-Johnson syndrome, toxic epidermal necrolysis."
303,OTEZLA,all-concat,"diarrhea, nausea, headache, discontinuation due to nausea, discontinuation due to diarrhea, discontinuation due to headache, discontinuation due to any adverse reaction, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, serious adverse reaction of nausea and vomiting, serious adverse reaction of diarrhea, serious adverse reaction of headache, abdominal pain, fatigue, insomnia, back pain, decrease appetite, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound), depression, weight decrease, drug interactions, increase in adverse reactions of depression, suicidal thoughts or behavior, weight decrease between 5%-10% of body weight, weight decrease of >=10% of body weight, loss of efficacy of OTEZLA due to strong cytochrome P450 enzyme inducers"
304,PICATO,all-concat,"ophthalmic adverse reaction, hypersensitivity reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis, severe eye pain, anaphylaxis"
305,POTIGA,all-concat,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior and ideation, withdrawal seizures, diplopia, blurred vision, nausea, constipation, dyspepsia, fatigue, asthenia, influenza, weight increased, memory impairment, tremor, vertigo, abnormal coordination, disturbance in attention, gait disturbance, aphasia, dysarthria, balance disorder, paresthesia, amnesia, dysphasia, confusional state, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, diarrhea, major bleeding, intracranial hemorrhage, hemorrhagic stroke, gastrointestinal bleeds, fatal bleeding, non-intracranial fatal bleed, gastrointestinal adverse reactions, dyspepsia, abdominal pain upper, abdominal discomfort, epigastric discomfort, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, myocardial infarction, thrombocytopenia, esophageal ulcer, thrombotic events, spinal/epidural hematoma"
307,PRISTIQ,all-concat,"hypersensitivity, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, insomnia, nervousness, abnormal dreams, urinary hesitation, yawning, hyperhidrosis, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion, proteinuria, Stevens-Johnson syndrome"
308,PROLIA,all-concat,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, pancreatitis, new malignancies, hypersensitivity reactions including anaphylaxis, musculoskeletal pain, suppression of bone turnover, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, cystitis, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, hypercholesterolemia, back pain, pain in extremity, musculoskeletal pain, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, severe symptomatic hypocalcemia, marked elevation in serum PTH, drug-related hypersensitivity reactions, facial swelling, erythema, severe bone, joint, muscle pain, significant suppression of bone turnover, bone remodeling, osteonecrosis, atypical fractures, delayed fracture healing, epidermal and dermal adverse events, dermatitis, eczema, rashes, incapacitating bone, joint, and/or muscle pain"
309,PROMACTA,all-concat,"hepatic decompensation, hepatotoxicity, thrombotic/thromboembolic complications, cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, headache, hyperbilirubinemia, cataract, fatigue, nausea, pain in extremity, dyspnea, dizziness, febrile neutropenia, abdominal pain, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, thrombotic microangiopathy, acute renal failure, portal vein thrombosis, abdominal pain, nausea, vomiting, diarrhea, portal vein thrombosis (PVT), symptoms of PVT including abdominal pain, nausea, vomiting, diarrhea."
310,QUTENZA,all-concat,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
311,SAPHRIS,all-concat,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity, Hepatotoxicity, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application Site Reactions, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive and Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Cerebrovascular Adverse Events, Stroke, Transient Ischemic Attack, Increased Mortality, Dementia-Related Psychosis, Hyperglycemia, Diabetes Mellitus, Dyslipidemia, Weight Gain, Hypersensitivity, Edema Peripheral, Dystonia, Extrapyramidal Symptoms, Parkinsonism, Oculogyration, Tremor, Oral Hypoesthesia, Oral Paresthesia, Transaminases Elevation, Creatine Kinase Elevation, Anemia, Thrombocytopenia, Temporary Bundle Branch Block, Accommodation Disorder, Swollen Tongue, Idiosyncratic Drug Reaction, Hyponatremia, Dysarthria, Diplopia, Vision Blurred, Gastroesophageal Reflux Disease, Fall, Photosensitivity Reaction, Enuresis, Choking, Oropharyngeal Muscular Dysfunction, Hypotension, Tachycardia, Dyspnea, Wheezing, Rash, Bradycardia, Respiratory Depression, Central Nervous System Depression, Myoglobinuria, Rhabdomyolysis, Acute Renal Failure, Galactorrhea, Amenorrhea, Gynecomastia, Impotence, Hyperinsulinemia, ALT Increased, AST Increased, Dehydration, Myalgia, Suicidal Ideation, Anger, Dysmenorrhea, Oropharyngeal Pain, Nasal Congestion, Dyspnea, Rash, Pyrexia, Feeling Hot, Aspiration Pneumonia"
312,SIMPONI,all-concat,"'serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, infusion reactions, immunogenicity, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions, congestive heart failure, demyelinating disorders, hepatitis B reactivation, hematologic cytopenias, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia'"
313,SIRTURO,all-concat,"'increased mortality, QT prolongation, hepatotoxicity, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, aminotransferase elevations, ventricular arrhythmia, liver injury, fatigue, anorexia, jaundice, dark urine, liver tenderness, hepatomegaly, total bilirubin elevation, aminotransferase elevations, clinically significant ventricular arrhythmia, QTcF interval of greater than 500 ms, syncope'"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, color vision change, non-arteritic anterior ischemic optic neuropathy (NAION), sudden loss of vision, prolonged erection, priapism, anatomical deformation of the penis, angulation, cavernosal fibrosis, Peyronie's disease, sickle cell anemia, multiple myeloma, leukemia, sudden decrease or loss of hearing, tinnitus, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, anti-aggregatory effect"
315,STRIBILD,all-concat,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity, Hepatotoxicity, Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, Nausea, Diarrhea, Ocular Icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal Dreams, Rash, Suicidal Ideation, Suicide Attempt, Skin Discoloration, Depression, Abdominal Pain, Dyspepsia, Vomiting, Fever, Pain, Nasopharyngitis, Pneumonia, Sinusitis, Upper Respiratory Tract Infection, Arthralgia, Back Pain, Myalgia, Paresthesia, Peripheral Neuropathy, Anxiety, Increased Cough, Rhinitis, Allergic Reaction, Angioedema, Hypokalemia, Hypophosphatemia, Dyspnea, Pancreatitis, Increased Amylase, Hepatic Steatosis, Hepatitis, Increased Liver Enzymes, Rhabdomyolysis, Osteomalacia, Muscular Weakness, Myopathy, Acute Renal Failure, Renal Failure, Acute Tubular Necrosis, Fanconi Syndrome, Proximal Renal Tubulopathy, Interstitial Nephritis, Nephrogenic Diabetes Insipidus, Renal Insufficiency, Proteinuria, Polyuria, Asthenia, Redistribution/Accumulation of Body Fat, Central Obesity, Dorsocervical Fat Enlargement (Buffalo Hump), Peripheral Wasting, Facial Wasting, Breast Enlargement, ""Cushingoid Appearance"", Autoimmune Disorders (Graves' Disease, Polymyositis, Guillain-Barre Syndrome)"
316,TAFINLAR,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, new primary malignancies, tumor promotion, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cuSCC, cough, constipation, nasopharyngitis, pancreatitis, hypersensitivity, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hyperglycemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT prolongation, retinal vein occlusion, interstitial lung disease, retinal pigment epithelial detachment, uveitis, iritis, renal failure, dehydration, insomnia, hemorrhage, dizziness, oropharyngeal pain, muscle spasms, pain in extremity, urinary tract infection, embryofetal toxicity."
317,TANZEUM,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, thyroid C-cell tumors, acute pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, gamma glutamyltransferase increase, heart rate increase'"
318,TECFIDERA,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia, difficulty breathing, urticaria, swelling of the throat and tongue, weakness on one side of the body, clumsiness of limbs, disturbance of vision, changes in thinking, memory, and orientation, confusion, personality changes."
319,TEFLARO,all-concat,"'hypersensitivity reactions, Clostridium difficile-associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, hypersensitivity, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis'"
320,TIVICAY,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, rash, depression, abnormal dreams, dizziness, nausea, diarrhea, vertigo, elevated ALT, elevated AST, increased creatine kinase, hyperglycemia, elevated lipase, neutropenia, elevated total bilirubin, worsening or development of transaminase elevations, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to infections, autoimmune disorders (Graves' disease, polymyositis, Guillain-Barre syndrome)"
321,TOVIAZ,all-concat,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, angina, chest pain, gastroenteritis, QT prolongation on ECG, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
322,TREANDA,all-concat,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension, hypersensitivity, hematologic toxicities, serious infections, opportunistic infections, increased toxicity, renal impairment, hepatic impairment, hepatotoxicity, myelosuppression-related adverse reactions, neutropenic sepsis, diffuse alveolar hemorrhage, pneumonia, opportunistic infection (CMV), febrile neutropenia, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, dysgeusia/taste disorder, atypical pneumonia, sepsis, herpes zoster, erythema, dermatitis, skin necrosis, anaphylaxis, injection or infusion site reactions, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, embryo-fetal toxicity"
323,TRULICITY,all-concat,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, sinus tachycardia, systemic hypersensitivity, injection-site reactions, PR interval prolongation, first degree AV block, amylase increase, lipase increase"
324,TUDORZA,all-concat,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, skin irritation, scalp irritation, application site pain, pruritus, erythema, pyoderma, ocular irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, neonatal toxicity, gasping syndrome, eye irritation, contact dermatitis"
326,ULORIC,all-concat,"'liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, twitching, tightness, weakness, musculoskeletal pain, stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, gout flare, cardiovascular thromboembolic events, myocardial infarction, stroke, hepatic failure, transaminase elevations, serum alanine aminotransferase (ALT) increase, aspartate aminotransferase (AST) increase, alkaline phosphatase increase, total bilirubin increase'"
327,VICTRELIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, gastrointestinal disorders, dysgeusia, dry mouth, vomiting, diarrhea, laboratory values, hemoglobin, neutrophils, platelets, blood and lymphatic system disorders, gastrointestinal disorders, infections and infestations, skin and subcutaneous tissue disorders, embryofetal toxicity, serious acute hypersensitivity reactions, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash"
328,VIMIZIM,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, acute respiratory complications, spinal or cervical cord compression'"
329,VIZAMYL,all-concat,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure"
330,VORAXAZE,all-concat,"Adverse reactions: 'serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, paresthesia, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor'"
331,XALKORI,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, hepatotoxicity, ILD, abdominal pain, pyrexia, weight increased, pain in extremity, muscle spasm, dizziness, headache, neuropathy, rash, renal cyst, syncope, neutropenia, lymphopenia, hypophosphatemia, ALT elevation, AST elevation, pneumonia, respiratory failure, sepsis, acute respiratory distress syndrome, arrhythmia, QTc prolongation, neutropenia, hypokalemia, hepatic failure, embryofetal toxicity"
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, cervical dystonia, neck pain, muscle weakness, injection site pain, musculoskeletal pain, blepharospasm, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, glabellar lines, facial paresis, injection site hematoma, eyelid edema, corneal exposure, corneal ulceration, ectropion, ptosis, dysphonia, dysarthria, urinary incontinence, breathing difficulties, respiratory failure, muscle spasm, dysarthria, myalgia, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia, hypersensitivity, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, respiratory disorders, respiratory failure, severe dysphagia, aspiration, neuromuscular disorders, amyotrophic lateral sclerosis, myasthenia gravis, Lambert-Eaton syndrome, severe dysphagia, respiratory compromise, corneal exposure, persistent epithelial defect, corneal ulceration, VII nerve disorders, narrow angle glaucoma, ectropion, ecchymosis, ptosis, Creutzfeldt-Jakob disease"
333,XIAFLEX,all-concat,"tendon ruptures, injury to the injected extremity, corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, flexor tendon rupture, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin tear, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, blood blister, injection site hematoma, ecchymosis, anaphylaxis, allergic reactions, IgE-anti-drug antibodies, risk of bleeding, ecchymosis/contusion, injection site hemorrhage"
334,XTANDI,all-concat,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, falls and fall-related injuries, hypertensive crisis"
335,YERVOY,all-concat,"'immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, gastrointestinal disorders, skin and subcutaneous tissue disorders, general disorders and administration site conditions, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, hypothyroidism, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis'"
336,ZERBAXA,all-concat,"'hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders, gastrointestinal disorders, general disorders and administration site conditions, infections and infestations, investigations, metabolism and nutrition disorders, nervous system disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, vascular disorders, decreased efficacy, serious hypersensitivity (anaphylactic) reactions, Clostridium difficile-associated diarrhea (CDAD), development of drug-resistant bacteria'"
337,ZYDELIG,all-concat,"'hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, neutropenia, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, nausea, vomiting, diarrhea, gastroesophageal reflux disease, stomatitis, headache, pyrexia, chills, pain, rash, pneumonia, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, ALT increased, AST increased, GGT increased, triglycerides (hypertriglyceridemia), hyperglycemia, hypoglycemia, hyponatremia, diarrhea, nausea, abdominal pain, vomiting, fatigue, pyrexia, asthenia, peripheral edema, upper respiratory tract infection, pneumonia, cough, dyspnea, rash, night sweats, headache, decreased appetite, insomnia, ALT increased, AST increased, neutrophils decreased, hemoglobin decreased, platelets decreased, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder'"
338,ZYKADIA,all-concat,"Adverse reactions: 'severe or persistent gastrointestinal toxicity, hepatotoxicity, interstitial lung disease/pneumonitis, QT interval prolongation, hyperglycemia, bradycardia, pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, hemoglobin decreased, alanine transaminase increased, aspartate transaminase increased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin increased, embryofetal toxicity'"
339,ZYTIGA,all-concat,"'hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, cardiac failure, non-infectious pneumonitis, myopathy, rhabdomyolysis, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, cardiovascular adverse reactions, cardiac failure, myocardial ischemia, myocardial infarction'"
